Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity-Reference-Cited by-同舟云学术

Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity

Published:2015-09 Issue:4 Volume:464 Page:1185-1191
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Li Xinyan,Li Fahong,Zhang Yao,Kang Yaoyue,Yu Jie,Yang Feifei,Liu Hongyan,Qin Yanli,Huang Yuxian,Mao Richeng,Zhang Jiming

Funder

National Natural Science Foundation of China

Major Science and Technology Special Project of China

“973” Project

Special Research Fund of Ministry of Health for Non-Profit Sector

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference32 articles.

1. Global epidemiology of hepatitis B virus;Custer;J. Clin. Gastroenterol.,2004

2. Chronic hepatitis B;Lok;Hepatology,2007

3. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B;Chen;Hepatology,2009

4. Benefits and risks of nucleoside analog therapy for hepatitis B;Dienstag;Hepatology,2009

5. Current developments in nucleoside/nucleotide analogues for hepatitis B;Lo;Expert Rev. Gastroenterol. Hepatol.,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-level viremia in nucleoside analog-treated chronic hepatitis B patients;Chinese Medical Journal;2021-11-10

2. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure;Antiviral Research;2021-08

3. Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment;Journal of Viral Hepatitis;2020-02-27